Log in  First Connection?

Breast: Archives News of the month

Evaluation of performance indicators of a national breast cancer screening program in Casablanca, Morocco
Breast
 6 min.

 Published on 08/04/2025 |  Original article (Abstract)  | Carvalho Melissa M. et al. | BMC Cancer 2025; 25(1): 612

Rising rates of cancer in the Middle East and North Africa have led the World Health Organization (WHO) to recommend that countries in the region develop sustainable cancer control strategies to address malignancies that most affect their populations [1]. In Morocco, breast cancer is the most commonly...

Distinct 5-methylcytosine profiles of LncRNA in breast cancer brain metastasis
Breast
 7 min.

 Published on 01/04/2025 |  Original article (Abstract)  | Wang Song et al. | BMC Cancer 2025; 25(1): 557

RNA post-transcriptional modifications are increasingly being studied in recent years [1, 2]. These modifications, which exceed 100 in number, include pseudouridine, N6-methyladenosine (m6A) [3], N1-methyladenosine (m1A) [4], and 5-methylcytosine (m5C) [5]. The important role of m6A modification for...

Relationship between neurotic personality traits with symptoms of post-traumatic stress disorder in breast cancer patients: with the mediation of self-efficacy and negative coping
Breast
 5 min.

 Published on 25/03/2025 |  Original article (Abstract)  | Zhou Qiao et al. | BMC Psychology 2025; 13(1): 282

Breast cancer ranks as one of the most prevalent malignant tumors globally. According to the Global Cancer Burden 2020 data, it accounts for about 11.7% of all new cancer cases worldwide, ranking first in the global cancer incidence rate [1]. In China alone, there are about 416,000 new cases of breast...

Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer
Breast
 4 min.

 Published on 18/03/2025 |  Original article (Abstract)  | Qian Li et al. | BMC Cancer 2025; 25(1): 453

Breast cancer poses the foremost threat to women’s health, exhibiting the highest incidence among female cancers and the second-highest mortality rate [1]. As the exploration of breast cancer treatment modalities progresses, neoadjuvant chemotherapy (NACT) has emerged as a standard clinical intervention,...

Comparison of the efficacy and safety of docetaxel plus capecitabine versus docetaxel plus epirubicin for human epidermal growth factor 2 -negative breast cancer: a meta-analysis
Breast
 4 min.

 Published on 11/03/2025 |  Original article (Abstract)  | Wu Jie et al. | BMC Women's Health 2025; 25(1): 103

Breast cancer is the most prevalent malignancy in women and poses a substantial global health burden. Approximately 2.3 million new cases have been reported, with an estimated 685,000 deaths attributed to this disease in 2020 [1]. Currently, treatment alternatives for breast cancer, especially metastatic...